Epidemiology and Clinical Course of PFAPA Syndrome in the Pediatric Population

preprint OA: closed
Full text JSON View at publisher

Abstract

Abstract Objective PFAPA syndrome is the most common autoinflammatory disease of childhood, with an as yet unknown etiology. It is characterized by recurrent, periodic episodes of fever accompanied by specific clinical features. Its pathogenesis and clinical course remain the subject of ongoing research. The aim of this study was to provide a detailed characterization of PFAPA syndrome in a large Polish pediatric cohort. Methods We conducted a retrospective cross-sectional study based on data from 47 children with a confirmed diagnosis of PFAPA syndrome. Data were collected using structured questionnaires. Detailed analyses included clinical manifestations, therapeutic approaches, and laboratory findings. Results The median age of the study population was 5 years, with a predominance of males (59.6%). In 91.5% of patients, the first episode of fever occurred before the age of 5 years. Febrile episodes lasted a mean of 5 days, with a median inter-episode interval of 3 weeks. The key clinical manifestations included cervical lymphadenopathy (91.5%), tonsillar exudates (85.1%), pharyngitis (74.5%), and oral aphthae (51.1%). During afebrile intervals, 87.2% of patients were free of symptoms. Laboratory evaluation showed elevated inflammatory markers, with a median C-reactive protein level of 6.9 mg/dL, a median erythrocyte sedimentation rate of 35.0 mm/h, and a mean neutrophil count of 11.8 × 10^3/µL. Prednisone treatment was effective in 97.6% of cases.
Full text 309,722 characters · extracted from preprint-html · click to expand
Epidemiology and Clinical Course of PFAPA Syndrome in the Pediatric Population | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Epidemiology and Clinical Course of PFAPA Syndrome in the Pediatric Population Natalia Gołuchowska, Agata Tomaszewska, Aldona Ząber, Agata Będzichowska, and 4 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-8368110/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Objective PFAPA syndrome is the most common autoinflammatory disease of childhood, with an as yet unknown etiology. It is characterized by recurrent, periodic episodes of fever accompanied by specific clinical features. Its pathogenesis and clinical course remain the subject of ongoing research. The aim of this study was to provide a detailed characterization of PFAPA syndrome in a large Polish pediatric cohort. Methods We conducted a retrospective cross-sectional study based on data from 47 children with a confirmed diagnosis of PFAPA syndrome. Data were collected using structured questionnaires. Detailed analyses included clinical manifestations, therapeutic approaches, and laboratory findings. Results The median age of the study population was 5 years, with a predominance of males (59.6%). In 91.5% of patients, the first episode of fever occurred before the age of 5 years. Febrile episodes lasted a mean of 5 days, with a median inter-episode interval of 3 weeks. The key clinical manifestations included cervical lymphadenopathy (91.5%), tonsillar exudates (85.1%), pharyngitis (74.5%), and oral aphthae (51.1%). During afebrile intervals, 87.2% of patients were free of symptoms. Laboratory evaluation showed elevated inflammatory markers, with a median C-reactive protein level of 6.9 mg/dL, a median erythrocyte sedimentation rate of 35.0 mm/h, and a mean neutrophil count of 11.8 × 10^3/µL. Prednisone treatment was effective in 97.6% of cases. PFAPA recurrent fever stomatitis pharyngitis cervical adenitis Figures Figure 1 Figure 2 Figure 3 Introduction PFAPA (periodic fever, aphthous stomatitis, pharyngitis, cervical adenopathy) is an autoinflammatory disorder of unknown etiology and a prototypical example of the so-called periodic fever syndromes. It occurs slightly more frequently in boys than in girls. The mean incidence is 0.86/10,000 in the general population and 2.6/10,000 among children under 5 years of age ( 1 , 2 ). Disease flares are characteristically regular, lasting 3–7 days and recurring every 2–8 weeks ( 3 ). During flares, patients typically present with pharyngitis, tonsillar exudates, oral aphthous ulcers, and cervical lymphadenopathy ( 4 ). Most patients also exhibit additional manifestations, most commonly abdominal pain ( 4 ). PFAPA syndrome is considered a self-limiting disease, characterized by a progressive lengthening of the intervals between febrile episodes and a shortening of their duration over time, ultimately leading to spontaneous resolution ( 5 ). Currently, there is no standardized diagnostic test that definitively confirms PFAPA. The diagnosis relies exclusively on clinical criteria, and a thorough medical history plays a pivotal role in the diagnostic process ( 4 ). To exclude alternative causes of febrile episodes, it is essential to rule out active infections, such as infectious mononucleosis and urinary tract infections, as well as other autoinflammatory diseases, including Familial Mediterranean Fever (FMF), Mevalonate Kinase Deficiency (MKD), Tumor Necrosis Factor Receptor–Associated Periodic Syndrome (TRAPS), and Cryopyrin-Associated Periodic Syndromes (CAPS). Basic laboratory investigations are recommended and should include a complete blood count with differential, with particular attention to inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which are typically elevated during disease flares (Table 1.). Measurement of procalcitonin (PCT) is also advised to help distinguish PFAPA from bacterial infections; in patients with PFAPA, PCT levels usually remain within the reference range or are only mildly elevated ( 6 ). In the peripheral blood count, determination of the absolute neutrophil count is crucial, as it enables differentiation from conditions such as cyclic neutropenia ( 7 ) (Fig. 1 .). Accurate and systematic observation of the patient over consecutive febrile episodes, with careful assessment of symptom dynamics, is key to establishing the diagnosis of PFAPA syndrome. Table 1. Main causes of periodic fevers in childhood. Source: Federici S, Gattorno M (2014) ( 8 ). In cases of suspected PFAPA syndrome, systemic glucocorticoids are the mainstay of treatment. Although they do not reduce the frequency of febrile episodes, they effectively alleviate symptoms during flares ( 10 ). Given the potential association between PFAPA and dysregulated immune responses, tonsillectomy is indicated in selected patients and may reduce the risk of symptom recurrence by up to 72% compared with pharmacological treatment alone ( 11 ). PFAPA is currently regarded as the most common periodic fever syndrome in children outside the Mediterranean region, underscoring the need to raise awareness of this condition among both healthcare professionals and parents ( 12 ). The development of more effective diagnostic methods is crucial to enable earlier recognition and timely initiation of appropriate therapeutic management. The available literature suggests a possible hereditary component of PFAPA, given the occurrence of similar febrile episodes in family histories, particularly in parents or siblings during childhood ( 13 ). This hypothesis is further supported by the resemblance of PFAPA to other genetically determined periodic fever syndromes. However, no single causative mutation has been identified, and current evidence instead points to a complex, polygenic genetic background ( 14 ). Despite growing awareness of PFAPA syndrome, substantial gaps in knowledge remain, particularly regarding long-term follow-up and the comparative effectiveness of different treatment strategies. The present study addresses these gaps by providing an analysis of the epidemiology and clinical course of PFAPA syndrome in a large Polish pediatric cohort, which has not previously been described in detail in our region. We offer a comprehensive characterization of affected children, including the frequency of clinical manifestations, the effectiveness of glucocorticoid therapy, and the role of tonsillectomy. The aim of this study was to provide an in-depth clinical characterization of children diagnosed with PFAPA syndrome and to identify factors associated with disease course. Materials and Methods The study had a cross-sectional design and was based on an analysis of questionnaire data obtained from parents of children with a diagnosis of PFAPA syndrome. Data were collected using a structured, parent-completed questionnaire. The questionnaire included information on the clinical presentation, treatment modalities, and results of laboratory investigations (where available). The study population consisted of children with PFAPA diagnosed according to the current clinical criteria. Participants were recruited via two pathways: online, through internet forums and social media groups for parents of children with PFAPA, and from among patients of the Department of Pediatrics, Nephrology and Pediatric Allergology, Military Institute of Medicine – National Research Institute (WIM-PIB) (n = 9). Online recruitment was conducted by posting an invitation to participate in the study. Parents were informed about the study objectives and provided informed consent by selecting the appropriate option in an online consent form. Complete medical documentation, including laboratory test results, was available for patients recruited from the Department of Pediatrics, Nephrology and Pediatric Allergology, WIM-PIB. The questionnaire contained both closed and open-ended items, allowing collection of qualitative and quantitative data. Questions addressed, among others: the child’s sex; symptoms accompanying recurrent fevers; symptoms occurring between episodes; normality of the child’s development; frequency and duration of episodes; history of tonsillectomy and its impact on symptoms; time to diagnosis; glucocorticoid treatment and its effectiveness; complete resolution of symptoms; and results of laboratory investigations. Initially, 56 children with periodic fever syndromes were enrolled. Ultimately, 47 patients who met the diagnostic criteria for PFAPA syndrome were included in the final analysis. Statistical methods The data were analyzed using SPSS Statistics for Windows, version 29.0.0.0 (IBM Corp., New York, NY, USA). Prior to analysis, data were preliminarily assessed with normality plots and subsequently tested using the Kolmogorov–Smirnov test with Lilliefors correction. Given that some variables did not follow a normal distribution, non-parametric tests not requiring normality were applied in those cases. Student’s t-test was used for variables with a normal distribution. Pearson’s linear correlation coefficient was calculated to assess correlations. A p-value < 0.05 was considered statistically significant. Due to the retrospective, questionnaire-based design of the study, the Bioethics Committee of the Military Institute of Medicine – National Research Institute exempted it from further ethical review (registration no. KB/61/25). Results Questionnaire surveys were completed for 56 children with a history of recurrent fevers. Ultimately, 47 patients with a confirmed diagnosis of PFAPA recurrent fever syndrome were included in the analysis. Age of participants The median age of the study population was 5.00 years (IQR: 4.00–7.00 years). Boys predominated (n = 28; 59.6%), while girls accounted for 19 (40.4%) participants. Most children demonstrated normal psychomotor development. Fever episodes In 91.5% of cases (n = 43), febrile episodes occurred before the age of 5 years. The median age at onset of the first fever episode was 2.00 years (IQR: 1.00–3.00 years). The median interval between consecutive febrile episodes was 3 weeks (IQR: 3.00–4.00 weeks), and individual episodes lasted a median of 5 days (IQR: 3.00–6.00 days). Clinical manifestations The most common symptom accompanying fever was cervical lymphadenopathy, observed in 43 children (91.5%). Pharyngitis or tonsillitis was reported in 35 patients (74.5%), while tonsillar exudates were present in 40 (85.1%). Oral aphthous ulcers occurred in 24 patients (51.1%). Skin lesions accompanied episodes in only 5 children (10.6%). Additional symptoms were reported in 28 children (59.6%), including: abdominal pain (n = 27/47; 57%), headache (n = 5/47; 11%), lower limb pain (n = 21/47; 45%), vomiting (n = 5/47; 11%), diarrhea (n = 2/47; 4%), conjunctivitis (n = 1/47; 2%), apathy and fatigue (n = 2/47; 6%), and dysuric symptoms (n = 1/47; 2%). Figure 2. presents the frequency of clinical features that constitute the diagnostic criteria for PFAPA syndrome. In the analyzed cohort, clinical features fulfilling the diagnostic criteria for PFAPA syndrome occurred with varying frequency. Nine children (19.1%) presented with one of the three principal manifestations, 22 patients (46.8%) exhibited two, and the full triad of three symptoms was observed in 16 children (34.0%). No significant differences were found between groups differing in the number of clinical features with respect to age at onset of the first fever episodes (p = 0.563), duration of afebrile intervals (p = 0.311), or time to diagnosis (p = 0.667). Likewise, the duration of febrile episodes did not differ significantly between children with one, two, or three manifestations (p = 0.906). In most patients (87.2%), no disease-related symptoms were observed during afebrile intervals. Only five children (10.6%) reported mild complaints between fever episodes. In this subgroup, abdominal pain was most common (8.5%), followed less frequently by respiratory symptoms—rhinitis (4.3%) and cough (2.1%). Headache and lower limb pain were reported sporadically (2.1% of cases each). Laboratory findings Laboratory data were available for nine children. Analysis of hematologic and biochemical parameters obtained during febrile episodes revealed elevated inflammatory markers. The mean absolute neutrophil count was 11.8 ± 3.7 × 10³/µL, and the mean neutrophil percentage in peripheral blood was 70.5 ± 9.7%. The median C‑reactive protein concentration was 6.9 mg/dL (IQR: 5.4–20.6 mg/dL), and the median erythrocyte sedimentation rate was 35.0 mm/h (IQR: 28.0–99.0). The mean procalcitonin level was 0.68 ± 0.36 ng/mL. Detailed laboratory parameters are presented in Table 2 . Table 2 Laboratory findings in children with PFAPA syndrome. Zmienna Wartość WBC [x10 9 /l]; mean (± SD) 8.59 (2.52) Neutrofile [10³/µL]; mean (± SD) 11.8 (3.7) Neutrofile [%]; mean (± SD) 70.5 (9.7) CRP [mg/dl]; median (IQR) 6.9 (5.4–20.6) OB [mm/h]; median (IQR) 35.0 (28.0–99.0) PCT [ng/ml]; mean (± SD) 0.68 (0.36) * SD – standard deviation; IQR – interquartile range Treatment Most patients (n = 41; 87.2%) received prednisone, whereas six children (12.8%) were not treated with this drug. Treatment was effective in 40 of 41 patients (97.6%), resulting in rapid clinical improvement and resolution of febrile symptoms during episodes. The effective prednisone dose was 1 mg/kg body weight (IQR: 1–1). In the majority of prednisone-treated children (n = 24; 58.5%), an extension of the interval between subsequent febrile episodes was observed, whereas no relevant change was noted in 29.3% (n = 12). In 12.2% (n = 5) of patients, a shortening of the inter-episode interval was reported (Fig. 3). Figure 3. Effect of prednisone treatment on the intervals between febrile episodes in children with PFAPA syndrome receiving glucocorticoid therapy (n = 41). In 12 children (25.5%), tonsillectomy was performed. Complete resolution of febrile episodes was achieved in 10 patients (83.3%), while a reduction in episode frequency was observed in 1 child (8.3%). No clinical benefit following surgery was reported in 1 patient (8.3%). Diagnosis The median time from symptom onset to diagnosis of PFAPA syndrome was 1 year (IQR: 1–2), with a minimum of less than 1 year and a maximum of 5 year. The mean duration of disease from diagnosis to remission was 3.12 ± 2.04 years. Discussion PFAPA syndrome is one of the most common causes of recurrent febrile episodes in children. The mechanisms triggering cyclic fever episodes are not yet fully understood; however, dysregulated activation of the innate immune response is considered a key factor in the pathogenesis of this condition ( 3 , 15 ). In the present study, we analyzed 56 children with a history of recurrent fevers. PFAPA syndrome was diagnosed in 47 of them, and these patients were included in the subsequent analyses. PFAPA typically occurs in children under 5 years of age ( 4 , 15 – 17 ). In our cohort, febrile episodes began before the age of 5 years in 91.5% of cases (43 children). Moreover, the median age at onset of the first febrile episode was 2 years, which is consistent with findings by Lazea, Rydenman, Yildiz, and Chen et al., who reported a median age at onset ranging from 1.5 to 3.5 years ( 17 , 18 ). We observed a slight predominance of boys (59.6%), in line with current epidemiological data indicating a higher incidence in males. Similar results were reported by Lazea et al., who found that boys accounted for 56.4% of cases ( 18 ). In our study, the median duration of febrile episodes was 5 days, and the median interval between episodes was approximately 3 weeks. These findings are consistent with the results reported by Rydenman, Moberg, and Luu et al., in which febrile episodes lasted 3–5 days and occurred every 3–5 weeks ( 19 , 22 , 23 ). The collected data confirm that PFAPA is a cyclical disease characterized by a recurrent pattern of febrile episodes. In most patients, both the duration of episodes and the intervals between them remain relatively stable and regular. Apart from high-grade fever, which was present in all patients, the most common clinical manifestations in our cohort were cervical lymphadenopathy (91.5%), pharyngitis or tonsillitis (74.5%), tonsillar exudates (85.1%), and oral aphthae (51.1%). The literature indicates that pharyngitis and tonsillitis occur in approximately 90% of patients and are frequently accompanied by mucosal erythema and whitish exudates on the tonsils. Cervical lymph node enlargement is observed in 53–94% of cases, while small, painful oral ulcers affect more than half of patients ( 18 , 19 , 21 , 22 , 24 , 25 ). Ezeh, Broide, and colleagues have reported cases in which PFAPA was associated with abdominal or joint pain ( 26 , 27 ). It should be emphasized that symptoms during febrile episodes usually do not occur simultaneously and vary in severity between patients. In the present study, no significant associations were found between the number of clinical manifestations and the age at onset of the first febrile episodes, the length of afebrile intervals, or the time to diagnosis. Moreover, there were no statistically significant differences in the duration of febrile episodes among patients presenting with one, two, or three clinical features. Laboratory results were analyzed in 9 patients. All showed elevated inflammatory markers (CRP, ESR, PCT). The mean values were: CRP 6.9 mg/dL, ESR 35 mm/h, and PCT 0.68 ng/mL. Similar findings were reported by Lazea and Chen et al., who described mean CRP values of 6.8 mg/L and 7.9 mg/dL and ESR values of 40 mm/h and 28.5 mm/h, respectively. In the study by Yazgan et al., the mean PCT concentration was 0.29 ± 0.14 ng/mL ( 18 , 21 , 28 ). High CRP and ESR levels together with moderately elevated PCT values are characteristic of febrile flares in PFAPA syndrome. These parameters reflect activation of the immune system and provide important diagnostic support in recognizing this condition. Pharmacologic treatment of PFAPA syndrome consists of oral glucocorticoids administered at a dose of 0.5–2 mg/kg on the first day of fever onset. These agents effectively alleviate symptoms but do not prevent disease recurrence. In approximately two-thirds of patients, a single dose is sufficient to achieve an antipyretic effect ( 29 ). In the absence of clinical response, a repeat dose after 24 hours is recommended. Only about 5% of patients show complete lack of response to this therapy ( 16 ). The characteristic rapid clinical response to glucocorticoids is also frequently used as an additional diagnostic criterion for PFAPA ( 29 ). The literature also highlights the role of maintenance and prophylactic therapies, such as colchicine at a dose of 0.5–1.25 mg/day and cimetidine at 10–20 mg/kg/day divided into two doses ( 25 , 30 ). In our study, prednisone at a dose of 1 mg/kg body weight proved effective, having been administered to 87.2% of patients and resulting in clinical improvement in 97.6% of cases. Only one child receiving oral glucocorticoids failed to respond to treatment. A similarly high efficacy of glucocorticoid therapy, ranging from 94% to 100%, has been reported by Lazea, Kanik, Yildiz, and Ezeh et al. ( 4 , 18 , 20 , 26 ). Prednisone treatment was associated with changes in the length of intervals between febrile episodes. In 58.5% of patients, an extension of inter-episode periods was observed, whereas in 12.2% these intervals became shorter. Lazea et al. reported that oral glucocorticoid administration prolonged the intervals between attacks in 13% of patients and shortened them in 35% ( 18 ). A shortening of inter-episode intervals in 46% of patients was also described by Broide et al. ( 27 ). These findings confirm that glucocorticoids are highly effective in rapidly terminating febrile episodes and alleviating PFAPA symptoms. Nevertheless, oral administration may paradoxically be associated with shorter afebrile intervals. This phenomenon has a complex background, potentially involving suboptimal treatment efficacy, the development of pharmacologic tolerance, or inappropriate adjustment of the therapeutic regimen. To optimize disease control and improve quality of life, close monitoring and careful, individualized dose titration are therefore essential. As noted above, pharmacologic treatment of PFAPA does not prevent disease recurrence. Tonsillectomy represents a key therapeutic option in affected children, with reported effectiveness ranging from 70% to 97% ( 4 , 11 , 14 , 20 , 21 , 23 , 27 , 31 – 33 ). In our study, tonsillectomy was performed in 25.5% of patients, resulting in complete remission in 83.3% of them. When analyzing factors influencing surgical outcomes, Hara et al. observed complete remission after tonsillectomy in 73.6% of children. Moreover, onset of PFAPA symptoms at ≥ 36 months of age and the presence of headache were associated with a higher likelihood of complete resolution following the procedure ( 34 ). To minimize the risk of complications and to accelerate recovery, clinical practice is increasingly shifting from classic tonsillectomy to tonsillotomy ( 30 ). This procedure is associated with a significantly lower risk of postoperative hemorrhage, reduced postoperative pain, and a faster return to daily activities. For these reasons, tonsillotomy is particularly recommended in younger children and in patients at increased risk of complications ( 28 ). Similar to tonsillectomy, tonsillotomy markedly reduces the number of febrile days during the course of the disease. Studies have shown that the difference in the cure rate between children undergoing tonsillotomy and those receiving conservative treatment alone is 40 percentage points, which represents a clinically meaningful therapeutic effect ( 35 ). An important consideration is the long-term effect of tonsillectomy in patients with recurrent fevers. Although long-term follow-up was not conducted in the present study, the literature provides evidence that the benefits of this procedure may persist for many years. In the study by Lantto et al., with a follow-up period of 9.8 years, as many as 95% of children maintained complete remission after surgery ( 35 ). Analysis of the relationship between disease relapse and prior tonsillectomy revealed that late recurrences were associated with regrowth of the palatine tonsils. In such cases, repeat tonsillectomy was performed, leading to restoration of remission in most patients ( 35 ). These observations are particularly relevant in the context of tonsillotomy, in which residual tonsillar lymphoid tissue may contribute to secondary hypertrophy ( 26 ). The correlation between tonsillar regrowth and disease relapse suggests that PFAPA‑associated inflammation may result from aberrant activation of immune cells within the tonsils, as well as from inflammatory signals originating in other tissues or from microbial stimuli ( 26 , 37 ). In our study, among the 34 children who did not undergo tonsillectomy, 11 (32.4%) reported complete resolution of symptoms. Broide et al. indicated that in most children, symptoms spontaneously abate before 14 years of age, confirming the self‑limiting nature of the disease ( 27 ). Nevertheless, this process is preceded by numerous episodes of recurrent fever, which often leads clinicians to consider tonsillectomy or the initiation of pharmacologic treatment ( 38 ). Studies suggest that later age at onset, absence of myalgia, and a good response to glucocorticoids may represent favorable prognostic factors for remission after tonsillectomy ( 20 , 33 ). Further prospective studies are needed to confirm these observations and to identify additional predictive factors. A major clinical concern is the issue of misdiagnosis and inappropriate antibiotic use in patients with unrecognized PFAPA syndrome. In their study, Rydenman et al. demonstrated a 61.8% reduction in antibiotic prescriptions following the establishment of a PFAPA diagnosis ( 39 ). This finding underscores the pivotal role of accurate differential diagnosis in limiting unnecessary antibiotic therapy, which has important public health implications in the context of rising antimicrobial resistance. These results highlight the need to increase clinicians’ awareness of the clinical features of PFAPA and to develop more effective diagnostic algorithms for this condition. Although the present study provides valuable descriptive information on PFAPA syndrome, it is subject to several important limitations. First, the retrospective and descriptive design, based on questionnaire data, limits the ability to draw causal inferences. Another significant concern is the recruitment method via internet portals, which may introduce selection bias. The resulting sample may not be representative of the general population of children with PFAPA. The retrospective collection of data through questionnaires also carries a risk of recall bias, potentially affecting the accuracy of information on age at symptom onset, episode frequency, and treatment effectiveness. It should also be noted that objective laboratory data, which are crucial for diagnosis and monitoring, were available for only a very small subgroup of patients (n = 9), precluding robust conclusions in this area. In light of these limitations, further research on PFAPA syndrome is essential. Future prospective studies involving larger patient cohorts are needed to confirm the present observations, reduce selection and recall bias, and provide data with greater statistical power. Such an approach will enable more reliable conclusions, contributing to a better understanding of the pathophysiology of PFAPA, improved diagnostic processes, and optimization of therapeutic strategies in this patient group. Conclusions This study, based on an analysis of cases in a Polish pediatric population, confirms the established epidemiologic and clinical profile of PFAPA syndrome, characterized by typical features of periodic fever and a favorable response to glucocorticoid therapy and tonsillectomy. These observations underscore the importance of early and accurate diagnosis to reduce unnecessary antibiotic use. Although the findings reinforce existing evidence, the retrospective design and limited sample size warrant caution in their interpretation. Abbreviations PFAPA - periodic fever, aphthous stomatitis, pharyngitis, cervical adenopathy FMF - Familial Mediterranean Fever MKD - Mevalonate Kinase Deficiency TRAPS - Tumor Necrosis Factor Receptor–Associated Periodic Syndrome CAPS - Cryopyrin‑Associated Periodic Syndromes CRP - C‑reactive protein ESR - Erythrocyte Sedimentation Rate PCT – Procalcitonin WIM-PIB - Military Institute of Medicine – National Research Institute WBC – White Blood Count Declarations Ethics approval and consent to participate Due to the retrospective, questionnaire‑based design of the study, the Bioethics Committee of the Military Institute of Medicine – National Research Institute exempted it from further ethical review (registration no. KB/61/25). Consent for publication Informed consent was obtained from all legal guardians of all study participants prior to their enrollment in the research. They were thoroughly informed about the study objectives, procedures, potential risks, and benefits, and they were given the opportunity to ask questions before providing their consent. Due to the retrospective, questionnaire‑based design of the study, the Bioethics Committee of the Military Institute of Medicine – National Research Institute exempted it from further ethical review (registration no. KB/61/25). Availability of data and materials The datasets used during the current review are available from the corresponding author on reasonable request. Competing interests The authors declare no conflicts of interest. Funding This research received no external funding. Authors' contributions Original concept of study: A.T., A.B.; Collection, recording and/or compilation of data N.G., A.K., A.K. .; analysis and interpretation of data: N.G., A.Z., A.B., A.T.; Writing of manuscript: N.G., A.T., A.K., A.K., A.T., A.B.; Critical review of manuscript: A.B., A.T., B.K., A.R.; Final approval of manuscript: B.K. A.R.; All authors have read and agreed to the published version of the manuscript. Acknowledgements Not applicable Clinical trial number Not applicable. References Rydenman K, Fjeld H, Hätting J, Berg S, Fasth A, Wekell P. Epidemiology and clinical features of PFAPA: a retrospective cohort study of 336 patients in western Sweden. Pediatr Rheumatol Online J. 2022;20(1):82. Hofer M, Pillet P, Cochard MM, Berg S, Krol P, Kone-Paut I, et al. International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology (Oxford). 2014;53(6):1125–9. Wang A, Manthiram K, Dedeoglu F, Licameli GR. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a review. World J Otorhinolaryngol Head Neck Surg. 2021;7(3):166–73. Kanık A, Eliaçık K, Kanık ET, Demirçelik Y, Demir BK. A comparative study for the clinical features in children with PFAPA syndrome who were diagnosed before and after the age of five. Int J Pediatr Otorhinolaryngol. 2022;158:111153. Wurster VM, Carlucci JG, Feder HM, Edwards KM. Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. J Pediatr. 2011;159(6):958–64. Kraszewska-Głomba B, Szymańska-Toczek Z, Szenborn L. Procalcitonin and C-reactive protein-based decision tree model for distinguishing PFAPA flares from acute infections. Bosn J Basic Med Sci. 2016;16(2):157–61. Wolska-Kuśnierz B, Mikołuć B, Motkowski R, Bernatowska E. PFAPA syndrome - common challenge for pediatrician, immunologist and otolaryngologist. Stand Med Pediatr. 2013;10:794–800. Federici S, Gattorno M. A practical approach to the diagnosis of autoinflammatory diseases in childhood. Best Pract Res Clin Rheumatol. 2014;28(2):263–76. Ahmadinejad Z, Mansori S, Ziaee V, Alijani N, Aghighi Y, Parvaneh N, et al. Periodic fever: a review on clinical, management and guideline for Iranian patients – Part I. Iran J Pediatr. 2014;24(1):1–13. Thomas KT, Feder HM, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999;135(1):15–21. Cavalcante LFF, Costa G, Battistuta SM, Makabe PF, Bueno ISF, Yuamoto B, et al. Surgical management for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome: a systematic review and meta-analysis. J Pediatr (Rio J). 2025;101(4):494–500. Anselmi F, Dusser P, Kone-Paut I. Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children - from pathogenesis to treatment strategies: a comprehensive review. Pediatr Drugs. 2025;27(5):575–92. Akelma AZ, Cizmeci MN, Kanburoglu MK, Mete E, Bozkaya D, Tufan N, et al. Is PFAPA syndrome really a sporadic disorder or is it genetic? Med Hypotheses. 2013;81(2):279–81. Manthiram K. What is PFAPA syndrome? Genetic clues about the pathogenesis. Curr Opin Rheumatol. 2023;35(6):423–8. Haracz J, Tadla M, Fleszar G, Postępski J. PFAPA syndrome in a 2-year-old girl: a case report and literature review. Pediatr Med Rodz. 2018;14(1):88–95. Vanoni F, Theodoropoulou K, Hofer M. PFAPA syndrome: a review on treatment and outcome. Pediatr Rheumatol Online J. 2016;14:38. Michailou M, Perdikogianni C. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: an update. Child (Basel). 2025;12(4):446. Lazea C, Damian L, Vulturar R, Lazar C. PFAPA syndrome: clinical, laboratory and therapeutic features in a single-centre cohort. Int J Gen Med. 2022;15:6871–80. Rydenman K, Fjeld H, Hätting J, Berg S, Fasth A, Wekell P. Epidemiology and clinical features of PFAPA: a retrospective cohort study of 336 patients in western Sweden. Pediatr Rheumatol Online J. 2022;20(1):82. Yildiz M, Haslak F, Adrovic A, Gucuyener N, Ulkersoy I, Koker O, et al. Independent risk factors for resolution of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome within 4 years after the disease onset. Clin Rheumatol. 2021;40(5):1959–65. Chen X, Li Y, Yang M, Shu Z, Mao H. Periodic fever syndromes in Chinese children and adolescents: a single-centre cohort study. Research Square [Preprint]. 2024. Available from: https://www.researchsquare.com/article/rs-4411739/v1 Moberg T, Rydenman K, Berg S, Fasth A, Wekell P. Long-term symptoms in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome after tonsillectomy. J Pediatr. 2025;278:114424. Luu I, Sharma A, Guaderrama M, Peru M, Nation J, Page N, et al. Immune dysregulation in the tonsillar microenvironment of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome. J Clin Immunol. 2020;40(1):179–90. Yıldız M, Haslak F, Adrovic A, Ülkersoy İ, Gücüyener N, Şahin S, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: a single-center experience. Turk Arch Pediatr. 2022;57(1):46–52. Zuchniak P, Godek G, Klajda K, Sidorczuk P, Król O, Wysokińska O. The PFAPA syndrome: review on diagnosis and management. J Educ Health Sport. 2022;12(12):67–73. Ezeh UC, Kahn PJ, April MM. Management of periodic fever, aphthous stomatitis, pharyngitis, and adenitis with intracapsular tonsillectomy. Laryngoscope. 2024;134(4):1967–9. Broide M, Levinsky Y, Tal R, Harel L, Shoham S, Abu Ahmad S, et al. Extreme periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA): a discrete group of patients. Pediatr Rheumatol Online J. 2023;21:59. Yazgan H, Keleş E, Yazgan Z, Gebeşçe A, Demirdöven M. C-reactive protein and procalcitonin during febrile attacks in PFAPA syndrome. Int J Pediatr Otorhinolaryngol. 2012;76(8):1145–7. Hausmann J, Dedeoglu F, Broderick L. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome and syndrome of unexplained recurrent fevers in children and adults. J Allergy Clin Immunol Pract. 2023;11(6):1676–87. Amarilyo G, Rothman D, Manthiram K, Edwards KM, Li SC, Marshall GS, et al. Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) PFAPA work group. Pediatr Rheumatol Online J. 2020;18(1):31. Banh Chong T, Sagot O, Alexis M, Brehin C, Brochard K, Gallois Y. Efficacy of partial tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: a STROBE retrospective observational study. Eur Ann Otorhinolaryngol Head Neck Dis. 2025;142(3):115–20. Rydenman K, Sparud-Lundin C, Karlsson-Bengtsson A, Berg S, Fasth A, Wekell P. Tonsillectomy reduces the family impact of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome and improves health-related quality of life in affected children. Orphanet J Rare Dis. 2023;18:146. Manthiram K, Ortega-Villa AM, Lapidus S, Bowes M, Romeo T, Garguilo K, et al. Features associated with response to tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome in children. J Pediatr. 2025;282:114559. Hara M, Morimoto N, Watabe T, Morisaki N, Matsumoto K. Can the effectiveness of tonsillectomy for PFAPA syndrome be predicted based on clinical factors. Int J Rheum Dis. 2023;26(3):480–6. Lantto U, Tapiainen T, Pokka T, Koivunen P, Helminen M, Piitulainen J, et al. Tonsillotomy for periodic fever syndrome: a randomized and controlled trial. Laryngoscope. 2024;134(2):968–72. Burton MJ, Pollard AJ, Ramsden JD, Chong LY, Venekamp RP. Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome (PFAPA). Cochrane Database Syst Rev. 2019;12:CD008669. Kaliszczuk M, Drążek K, Stańczyk M, Tkaczyk M. Periodic fever in everyday paediatric practice - case report of 6-year-old girl and a literature review. Pediatr Med Rodz. 2020;16(1):100–3. Mrówka-Kata K, Kata D, Miśkiewicz-Orczyk K, Namysłowski P. PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, cervical adenopathy). Ann Acad Med Siles. 2012;66(1):57–9. Rydenman K, Berg S, Karlsson-Bengtsson A, Fasth A, Wekell P. Antibiotic prescriptions to children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis. Acta Paediatr. 2024;113(8):1927–33. Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-8368110","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":565311266,"identity":"1ec9b912-33a1-4354-ba5b-54ada179d58f","order_by":0,"name":"Natalia Gołuchowska","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA6UlEQVRIiWNgGAWjYHACxgMMDEDEwMbA8IFBAiTQCORa4NUD18I4A6KlAciVIE4LMw9CBLcWc/7FBw7z1NyRMzh/LPGzbZtFNIPY4YYDjDtwa7Gc8SzhMM+xZ8YGN9IOS+e2SeQ2SCcCtZzBrcXgxhmDw7wNhxO33WBvkM7dBtPSRoyW88ebf1sSpeV8D1TLgbRj0ozE2cKWcHDOscPG9jfS0ix7/0nktoG0JOLzy/nDBx+8qTksJ9l/zPjGjzN1uf3S6Q8ffNxhg1MLg0QCmgAbiEhswK2Dgf8ANlFGfFpGwSgYBaNgpAEAOGZiK8rjj4MAAAAASUVORK5CYII=","orcid":"","institution":"Military Institute of Medicine - National Research Institute","correspondingAuthor":true,"prefix":"","firstName":"Natalia","middleName":"","lastName":"Gołuchowska","suffix":""},{"id":565311268,"identity":"e87f95b4-644b-4c05-bb03-0af2d54c178c","order_by":1,"name":"Agata Tomaszewska","email":"","orcid":"","institution":"Military Institute of Medicine - National Research Institute","correspondingAuthor":false,"prefix":"","firstName":"Agata","middleName":"","lastName":"Tomaszewska","suffix":""},{"id":565311270,"identity":"3736b2e6-eb15-4831-bea6-aa7453a77f71","order_by":2,"name":"Aldona Ząber","email":"","orcid":"","institution":"Military Institute of Medicine - National Research Institute","correspondingAuthor":false,"prefix":"","firstName":"Aldona","middleName":"","lastName":"Ząber","suffix":""},{"id":565311273,"identity":"aac03651-7e11-4be5-b6d0-49ff4f5ba526","order_by":3,"name":"Agata Będzichowska","email":"","orcid":"","institution":"Military Institute of Medicine - National Research Institute","correspondingAuthor":false,"prefix":"","firstName":"Agata","middleName":"","lastName":"Będzichowska","suffix":""},{"id":565311274,"identity":"b228db80-0d74-4324-afc4-d240dfa437a2","order_by":4,"name":"Agata Knapik","email":"","orcid":"","institution":"University of Warsaw","correspondingAuthor":false,"prefix":"","firstName":"Agata","middleName":"","lastName":"Knapik","suffix":""},{"id":565311282,"identity":"a860636d-ff5c-4ff9-aae5-f73e919b6337","order_by":5,"name":"Aleksandra Kudiuk","email":"","orcid":"","institution":"University of Warsaw","correspondingAuthor":false,"prefix":"","firstName":"Aleksandra","middleName":"","lastName":"Kudiuk","suffix":""},{"id":565311283,"identity":"2144e7ac-ab77-4241-a31f-3e0325e49900","order_by":6,"name":"Agnieszka Rustecka","email":"","orcid":"","institution":"Military Institute of Medicine - National Research Institute","correspondingAuthor":false,"prefix":"","firstName":"Agnieszka","middleName":"","lastName":"Rustecka","suffix":""},{"id":565311284,"identity":"feeb5c0f-2837-4a76-b426-cbe7fa4dd93b","order_by":7,"name":"Bolesław Kalicki","email":"","orcid":"","institution":"Military Institute of Medicine - National Research Institute","correspondingAuthor":false,"prefix":"","firstName":"Bolesław","middleName":"","lastName":"Kalicki","suffix":""}],"badges":[],"createdAt":"2025-12-15 15:53:31","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-8368110/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-8368110/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":99313197,"identity":"1d89e286-2791-4923-aaf9-89707fcc434e","added_by":"auto","created_at":"2025-12-31 16:19:54","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":329566,"visible":true,"origin":"","legend":"","description":"","filename":"pfapa17.12.docx","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/db2337ab13cd7ca6d4f3f238.docx"},{"id":99034927,"identity":"8ebf98db-abb7-43bf-994a-c6d25116dd6b","added_by":"auto","created_at":"2025-12-26 09:47:46","extension":"json","order_by":1,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":9394,"visible":true,"origin":"","legend":"","description":"","filename":"56d25b0f301c479f874cb8c73baaf148.json","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/09ef6a342c16a57f00c90e02.json"},{"id":99034928,"identity":"ad77f6e4-67cd-4bb8-8c95-7f839c18bc1e","added_by":"auto","created_at":"2025-12-26 09:47:46","extension":"xml","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":101625,"visible":true,"origin":"","legend":"","description":"","filename":"56d25b0f301c479f874cb8c73baaf1481enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/6b6a4049a8644439e6d29752.xml"},{"id":99034936,"identity":"f3eb2a5d-b324-426e-98de-5e2bc591b1cf","added_by":"auto","created_at":"2025-12-26 09:47:46","extension":"emf","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":793636,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage1.emf","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/dd457a71b4f5f0048dcbdb34.emf"},{"id":99314482,"identity":"113239d0-3791-4971-8f5b-c3bec752620e","added_by":"auto","created_at":"2025-12-31 16:21:34","extension":"emf","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":4706520,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage2.emf","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/8c2d1d77de8cdaf3763f3549.emf"},{"id":99034933,"identity":"67ab7faa-2440-40d5-96cf-cc05c275de18","added_by":"auto","created_at":"2025-12-26 09:47:46","extension":"emf","order_by":6,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":2110176,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage3.emf","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/793ddcf23e62a74a87706530.emf"},{"id":99313488,"identity":"d28ab8c7-4c75-44ec-8e30-74dd261684e7","added_by":"auto","created_at":"2025-12-31 16:20:14","extension":"png","order_by":7,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":7973,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/8bf1685deb6e7991256b5c4a.png"},{"id":99034931,"identity":"9228fa8d-8650-43d6-967c-7127951b704e","added_by":"auto","created_at":"2025-12-26 09:47:46","extension":"png","order_by":8,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":23760,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/1929f989f126e2642a11111a.png"},{"id":99314419,"identity":"8efc2ca2-3366-4204-9c5b-c64bfa89d939","added_by":"auto","created_at":"2025-12-31 16:21:24","extension":"png","order_by":9,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":9919,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage3.png","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/7a0a8c1eb7726dd84c0f6d7e.png"},{"id":99313327,"identity":"35b6ac99-1b15-4c26-b96a-ff7421d7e214","added_by":"auto","created_at":"2025-12-31 16:20:00","extension":"xml","order_by":10,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":98594,"visible":true,"origin":"","legend":"","description":"","filename":"56d25b0f301c479f874cb8c73baaf1481structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/af5efbc8e4af2b3e2a94c0a9.xml"},{"id":99034938,"identity":"4f322ac7-d6e4-4464-a1ad-0b46c96f81bf","added_by":"auto","created_at":"2025-12-26 09:47:46","extension":"html","order_by":11,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":111560,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/c75686c679c5499c0bb10756.html"},{"id":99201517,"identity":"6c1c495e-cd80-4c84-a2bf-870f70d12237","added_by":"auto","created_at":"2025-12-30 04:44:25","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":82651,"visible":true,"origin":"","legend":"\u003cp\u003eInitial differential diagnosis of recurrent fevers based on laboratory investigations. Source: authors’ own adaptation based on Ahmadinejad Z et al. (2014) (9) and Kraszewska‑Głomba B et al. (2016) (6).\u003c/p\u003e","description":"","filename":"19.png","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/05d34bf343a479a07fb96fdd.png"},{"id":99201518,"identity":"caf7d165-fc40-4a79-9d1b-d822f5f80e3e","added_by":"auto","created_at":"2025-12-30 04:44:25","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":27326,"visible":true,"origin":"","legend":"\u003cp\u003eFrequency of clinical signs constituting the diagnostic criteria for PFAPA syndrome.\u003c/p\u003e","description":"","filename":"28.png","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/c20147736f7f23de29c6b28e.png"},{"id":99201519,"identity":"f0ab57ae-7075-4e76-b0f3-b4ec9ae0f63c","added_by":"auto","created_at":"2025-12-30 04:44:25","extension":"png","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":39384,"visible":true,"origin":"","legend":"\u003cp\u003eEffect of prednisone treatment on the intervals between febrile episodes in children with PFAPA syndrome receiving glucocorticoid therapy (n = 41).\u003c/p\u003e","description":"","filename":"37.png","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/cf8d058711965241aa97cf98.png"},{"id":100359803,"identity":"d011e174-bda2-4c75-9a60-41f3c7c25c58","added_by":"auto","created_at":"2026-01-16 07:25:57","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":764018,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-8368110/v1/4e295645-95d5-4301-aeb1-563b0d80351a.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Epidemiology and Clinical Course of PFAPA Syndrome in the Pediatric Population","fulltext":[{"header":"Introduction","content":"\u003cp\u003ePFAPA (periodic fever, aphthous stomatitis, pharyngitis, cervical adenopathy) is an autoinflammatory disorder of unknown etiology and a prototypical example of the so-called periodic fever syndromes. It occurs slightly more frequently in boys than in girls. The mean incidence is 0.86/10,000 in the general population and 2.6/10,000 among children under 5 years of age (\u003cspan class=\"CitationRef\"\u003e1\u003c/span\u003e, \u003cspan class=\"CitationRef\"\u003e2\u003c/span\u003e). Disease flares are characteristically regular, lasting 3\u0026ndash;7 days and recurring every 2\u0026ndash;8 weeks (\u003cspan class=\"CitationRef\"\u003e3\u003c/span\u003e). During flares, patients typically present with pharyngitis, tonsillar exudates, oral aphthous ulcers, and cervical lymphadenopathy (\u003cspan class=\"CitationRef\"\u003e4\u003c/span\u003e). Most patients also exhibit additional manifestations, most commonly abdominal pain (\u003cspan class=\"CitationRef\"\u003e4\u003c/span\u003e).\u003c/p\u003e\n\u003cp\u003ePFAPA syndrome is considered a self-limiting disease, characterized by a progressive lengthening of the intervals between febrile episodes and a shortening of their duration over time, ultimately leading to spontaneous resolution (\u003cspan class=\"CitationRef\"\u003e5\u003c/span\u003e). Currently, there is no standardized diagnostic test that definitively confirms PFAPA. The diagnosis relies exclusively on clinical criteria, and a thorough medical history plays a pivotal role in the diagnostic process (\u003cspan class=\"CitationRef\"\u003e4\u003c/span\u003e).\u003c/p\u003e\n\u003cp\u003eTo exclude alternative causes of febrile episodes, it is essential to rule out active infections, such as infectious mononucleosis and urinary tract infections, as well as other autoinflammatory diseases, including Familial Mediterranean Fever (FMF), Mevalonate Kinase Deficiency (MKD), Tumor Necrosis Factor Receptor\u0026ndash;Associated Periodic Syndrome (TRAPS), and Cryopyrin-Associated Periodic Syndromes (CAPS). Basic laboratory investigations are recommended and should include a complete blood count with differential, with particular attention to inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which are typically elevated during disease flares (Table\u0026nbsp;1.). Measurement of procalcitonin (PCT) is also advised to help distinguish PFAPA from bacterial infections; in patients with PFAPA, PCT levels usually remain within the reference range or are only mildly elevated (\u003cspan class=\"CitationRef\"\u003e6\u003c/span\u003e). In the peripheral blood count, determination of the absolute neutrophil count is crucial, as it enables differentiation from conditions such as cyclic neutropenia (\u003cspan class=\"CitationRef\"\u003e7\u003c/span\u003e) (Fig. \u003cspan class=\"InternalRef\"\u003e1\u003c/span\u003e.).\u003c/p\u003e\n\u003cp\u003eAccurate and systematic observation of the patient over consecutive febrile episodes, with careful assessment of symptom dynamics, is key to establishing the diagnosis of PFAPA syndrome.\u003c/p\u003e\n\u003cp\u003eTable 1. Main causes of periodic fevers in childhood.\u003c/p\u003e\n\u003cp\u003e\u003cimg src=\"data:image/png;base64,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\"\u003e\u003c/p\u003e\n\u003cp\u003eSource: Federici S, Gattorno M (2014) (\u003cspan class=\"CitationRef\"\u003e8\u003c/span\u003e).\u003c/p\u003e\n\u003cp\u003eIn cases of suspected PFAPA syndrome, systemic glucocorticoids are the mainstay of treatment. Although they do not reduce the frequency of febrile episodes, they effectively alleviate symptoms during flares (\u003cspan class=\"CitationRef\"\u003e10\u003c/span\u003e).\u003c/p\u003e\n\u003cp\u003eGiven the potential association between PFAPA and dysregulated immune responses, tonsillectomy is indicated in selected patients and may reduce the risk of symptom recurrence by up to 72% compared with pharmacological treatment alone (\u003cspan class=\"CitationRef\"\u003e11\u003c/span\u003e).\u003c/p\u003e\n\u003cp\u003ePFAPA is currently regarded as the most common periodic fever syndrome in children outside the Mediterranean region, underscoring the need to raise awareness of this condition among both healthcare professionals and parents (\u003cspan class=\"CitationRef\"\u003e12\u003c/span\u003e).\u003c/p\u003e\n\u003cp\u003eThe development of more effective diagnostic methods is crucial to enable earlier recognition and timely initiation of appropriate therapeutic management. The available literature suggests a possible hereditary component of PFAPA, given the occurrence of similar febrile episodes in family histories, particularly in parents or siblings during childhood (\u003cspan class=\"CitationRef\"\u003e13\u003c/span\u003e). This hypothesis is further supported by the resemblance of PFAPA to other genetically determined periodic fever syndromes. However, no single causative mutation has been identified, and current evidence instead points to a complex, polygenic genetic background (\u003cspan class=\"CitationRef\"\u003e14\u003c/span\u003e).\u003c/p\u003e\n\u003cp\u003eDespite growing awareness of PFAPA syndrome, substantial gaps in knowledge remain, particularly regarding long-term follow-up and the comparative effectiveness of different treatment strategies.\u003c/p\u003e\n\u003cp\u003eThe present study addresses these gaps by providing an analysis of the epidemiology and clinical course of PFAPA syndrome in a large Polish pediatric cohort, which has not previously been described in detail in our region. We offer a comprehensive characterization of affected children, including the frequency of clinical manifestations, the effectiveness of glucocorticoid therapy, and the role of tonsillectomy.\u003c/p\u003e\n\u003cp\u003eThe aim of this study was to provide an in-depth clinical characterization of children diagnosed with PFAPA syndrome and to identify factors associated with disease course.\u003c/p\u003e"},{"header":"Materials and Methods","content":"\u003cp\u003eThe study had a cross-sectional design and was based on an analysis of questionnaire data obtained from parents of children with a diagnosis of PFAPA syndrome. Data were collected using a structured, parent-completed questionnaire. The questionnaire included information on the clinical presentation, treatment modalities, and results of laboratory investigations (where available). The study population consisted of children with PFAPA diagnosed according to the current clinical criteria.\u003c/p\u003e \u003cp\u003e Participants were recruited via two pathways: online, through internet forums and social media groups for parents of children with PFAPA, and from among patients of the Department of Pediatrics, Nephrology and Pediatric Allergology, Military Institute of Medicine \u0026ndash; National Research Institute (WIM-PIB) (n\u0026thinsp;=\u0026thinsp;9). Online recruitment was conducted by posting an invitation to participate in the study.\u003c/p\u003e \u003cp\u003e Parents were informed about the study objectives and provided informed consent by selecting the appropriate option in an online consent form.\u003c/p\u003e \u003cp\u003eComplete medical documentation, including laboratory test results, was available for patients recruited from the Department of Pediatrics, Nephrology and Pediatric Allergology, WIM-PIB. The questionnaire contained both closed and open-ended items, allowing collection of qualitative and quantitative data. Questions addressed, among others: the child\u0026rsquo;s sex; symptoms accompanying recurrent fevers; symptoms occurring between episodes; normality of the child\u0026rsquo;s development; frequency and duration of episodes; history of tonsillectomy and its impact on symptoms; time to diagnosis; glucocorticoid treatment and its effectiveness; complete resolution of symptoms; and results of laboratory investigations.\u003c/p\u003e \u003cp\u003eInitially, 56 children with periodic fever syndromes were enrolled. Ultimately, 47 patients who met the diagnostic criteria for PFAPA syndrome were included in the final analysis.\u003c/p\u003e \u003cp\u003eStatistical methods\u003c/p\u003e \u003cp\u003eThe data were analyzed using SPSS Statistics for Windows, version 29.0.0.0 (IBM Corp., New York, NY, USA). Prior to analysis, data were preliminarily assessed with normality plots and subsequently tested using the Kolmogorov\u0026ndash;Smirnov test with Lilliefors correction. Given that some variables did not follow a normal distribution, non-parametric tests not requiring normality were applied in those cases. Student\u0026rsquo;s t-test was used for variables with a normal distribution. Pearson\u0026rsquo;s linear correlation coefficient was calculated to assess correlations. A p-value\u0026thinsp;\u0026lt;\u0026thinsp;0.05 was considered statistically significant.\u003c/p\u003e \u003cp\u003eDue to the retrospective, questionnaire-based design of the study, the Bioethics Committee of the Military Institute of Medicine \u0026ndash; National Research Institute exempted it from further ethical review (registration no. KB/61/25).\u003c/p\u003e"},{"header":"Results","content":"\u003cp\u003eQuestionnaire surveys were completed for 56 children with a history of recurrent fevers. Ultimately, 47 patients with a confirmed diagnosis of PFAPA recurrent fever syndrome were included in the analysis.\u003c/p\u003e\n\u003cp\u003eAge of participants\u003c/p\u003e\n\u003cp\u003eThe median age of the study population was 5.00 years (IQR: 4.00\u0026ndash;7.00 years). Boys predominated (n\u0026thinsp;=\u0026thinsp;28; 59.6%), while girls accounted for 19 (40.4%) participants. Most children demonstrated normal psychomotor development.\u003c/p\u003e\n\u003cp\u003eFever episodes\u003c/p\u003e\n\u003cp\u003eIn 91.5% of cases (n\u0026thinsp;=\u0026thinsp;43), febrile episodes occurred before the age of 5 years. The median age at onset of the first fever episode was 2.00 years (IQR: 1.00\u0026ndash;3.00 years). The median interval between consecutive febrile episodes was 3 weeks (IQR: 3.00\u0026ndash;4.00 weeks), and individual episodes lasted a median of 5 days (IQR: 3.00\u0026ndash;6.00 days).\u003c/p\u003e\n\u003cp\u003eClinical manifestations\u003c/p\u003e\n\u003cp\u003eThe most common symptom accompanying fever was cervical lymphadenopathy, observed in 43 children (91.5%). Pharyngitis or tonsillitis was reported in 35 patients (74.5%), while tonsillar exudates were present in 40 (85.1%). Oral aphthous ulcers occurred in 24 patients (51.1%). Skin lesions accompanied episodes in only 5 children (10.6%).\u003c/p\u003e\n\u003cp\u003eAdditional symptoms were reported in 28 children (59.6%), including: abdominal pain (n\u0026thinsp;=\u0026thinsp;27/47; 57%), headache (n\u0026thinsp;=\u0026thinsp;5/47; 11%), lower limb pain (n\u0026thinsp;=\u0026thinsp;21/47; 45%), vomiting (n\u0026thinsp;=\u0026thinsp;5/47; 11%), diarrhea (n\u0026thinsp;=\u0026thinsp;2/47; 4%), conjunctivitis (n\u0026thinsp;=\u0026thinsp;1/47; 2%), apathy and fatigue (n\u0026thinsp;=\u0026thinsp;2/47; 6%), and dysuric symptoms (n\u0026thinsp;=\u0026thinsp;1/47; 2%). Figure\u0026nbsp;2. presents the frequency of clinical features that constitute the diagnostic criteria for PFAPA syndrome.\u003c/p\u003e\n\u003cp\u003eIn the analyzed cohort, clinical features fulfilling the diagnostic criteria for PFAPA syndrome occurred with varying frequency. Nine children (19.1%) presented with one of the three principal manifestations, 22 patients (46.8%) exhibited two, and the full triad of three symptoms was observed in 16 children (34.0%). No significant differences were found between groups differing in the number of clinical features with respect to age at onset of the first fever episodes (p\u0026thinsp;=\u0026thinsp;0.563), duration of afebrile intervals (p\u0026thinsp;=\u0026thinsp;0.311), or time to diagnosis (p\u0026thinsp;=\u0026thinsp;0.667). Likewise, the duration of febrile episodes did not differ significantly between children with one, two, or three manifestations (p\u0026thinsp;=\u0026thinsp;0.906).\u003c/p\u003e\n\u003cp\u003eIn most patients (87.2%), no disease-related symptoms were observed during afebrile intervals. Only five children (10.6%) reported mild complaints between fever episodes. In this subgroup, abdominal pain was most common (8.5%), followed less frequently by respiratory symptoms\u0026mdash;rhinitis (4.3%) and cough (2.1%). Headache and lower limb pain were reported sporadically (2.1% of cases each).\u003c/p\u003e\n\u003cp\u003eLaboratory findings\u003c/p\u003e\n\u003cp\u003eLaboratory data were available for nine children. Analysis of hematologic and biochemical parameters obtained during febrile episodes revealed elevated inflammatory markers. The mean absolute neutrophil count was 11.8\u0026thinsp;\u0026plusmn;\u0026thinsp;3.7 \u0026times; 10\u0026sup3;/\u0026micro;L, and the mean neutrophil percentage in peripheral blood was 70.5\u0026thinsp;\u0026plusmn;\u0026thinsp;9.7%. The median C‑reactive protein concentration was 6.9 mg/dL (IQR: 5.4\u0026ndash;20.6 mg/dL), and the median erythrocyte sedimentation rate was 35.0 mm/h (IQR: 28.0\u0026ndash;99.0). The mean procalcitonin level was 0.68\u0026thinsp;\u0026plusmn;\u0026thinsp;0.36 ng/mL. Detailed laboratory parameters are presented in Table\u0026nbsp;\u003cspan class=\"InternalRef\"\u003e2\u003c/span\u003e.\u003c/p\u003e\n\u003cdiv class=\"gridtable\"\u003e\n\u003ctable id=\"Tab1\" border=\"1\"\u003e\u003ccaption\u003e\n\u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e\n\u003cdiv class=\"CaptionContent\"\u003e\n\u003cp\u003eLaboratory findings in children with PFAPA syndrome.\u003c/p\u003e\n\u003c/div\u003e\n\u003c/caption\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003e\n\u003cp\u003eZmienna\u003c/p\u003e\n\u003c/th\u003e\n\u003cth align=\"left\"\u003e\n\u003cp\u003eWartość\u003c/p\u003e\n\u003c/th\u003e\n\u003c/tr\u003e\n\u003c/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eWBC [x10\u003csup\u003e9\u003c/sup\u003e/l]; mean (\u0026plusmn;\u0026thinsp;SD)\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"char\" char=\".\"\u003e\n\u003cp\u003e8.59 (2.52)\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eNeutrofile [10\u0026sup3;/\u0026micro;L]; mean (\u0026plusmn;\u0026thinsp;SD)\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"char\" char=\".\"\u003e\n\u003cp\u003e11.8 (3.7)\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eNeutrofile [%]; mean (\u0026plusmn;\u0026thinsp;SD)\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"char\" char=\".\"\u003e\n\u003cp\u003e70.5 (9.7)\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eCRP [mg/dl]; median (IQR)\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"char\" char=\".\"\u003e\n\u003cp\u003e6.9 (5.4\u0026ndash;20.6)\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003eOB [mm/h]; median (IQR)\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"char\" char=\".\"\u003e\n\u003cp\u003e35.0 (28.0\u0026ndash;99.0)\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003ctr\u003e\n\u003ctd align=\"left\"\u003e\n\u003cp\u003ePCT [ng/ml]; mean (\u0026plusmn;\u0026thinsp;SD)\u003c/p\u003e\n\u003c/td\u003e\n\u003ctd align=\"char\" char=\".\"\u003e\n\u003cp\u003e0.68 (0.36)\u003c/p\u003e\n\u003c/td\u003e\n\u003c/tr\u003e\n\u003c/tbody\u003e\n\u003ctfoot\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003e* SD \u0026ndash; standard deviation; IQR \u0026ndash; interquartile range\u003c/td\u003e\n\u003c/tr\u003e\n\u003c/tfoot\u003e\n\u003c/table\u003e\n\u003c/div\u003e\n\u003cp\u003eTreatment\u003c/p\u003e\n\u003cp\u003eMost patients (n\u0026thinsp;=\u0026thinsp;41; 87.2%) received prednisone, whereas six children (12.8%) were not treated with this drug. Treatment was effective in 40 of 41 patients (97.6%), resulting in rapid clinical improvement and resolution of febrile symptoms during episodes. The effective prednisone dose was 1 mg/kg body weight (IQR: 1\u0026ndash;1).\u003c/p\u003e\n\u003cp\u003eIn the majority of prednisone-treated children (n\u0026thinsp;=\u0026thinsp;24; 58.5%), an extension of the interval between subsequent febrile episodes was observed, whereas no relevant change was noted in 29.3% (n\u0026thinsp;=\u0026thinsp;12). In 12.2% (n\u0026thinsp;=\u0026thinsp;5) of patients, a shortening of the inter-episode interval was reported (Fig.\u0026nbsp;3).\u003c/p\u003e\n\u003cp\u003eFigure 3. Effect of prednisone treatment on the intervals between febrile episodes in children with PFAPA syndrome receiving glucocorticoid therapy (n\u0026thinsp;=\u0026thinsp;41).\u003c/p\u003e\n\u003cp\u003eIn 12 children (25.5%), tonsillectomy was performed. Complete resolution of febrile episodes was achieved in 10 patients (83.3%), while a reduction in episode frequency was observed in 1 child (8.3%). No clinical benefit following surgery was reported in 1 patient (8.3%).\u003c/p\u003e\n\u003cp\u003eDiagnosis\u003c/p\u003e\n\u003cp\u003eThe median time from symptom onset to diagnosis of PFAPA syndrome was 1 year (IQR: 1\u0026ndash;2), with a minimum of less than 1 year and a maximum of 5 year.\u003c/p\u003e\n\u003cp\u003eThe mean duration of disease from diagnosis to remission was 3.12\u0026thinsp;\u0026plusmn;\u0026thinsp;2.04 years.\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003ePFAPA syndrome is one of the most common causes of recurrent febrile episodes in children. The mechanisms triggering cyclic fever episodes are not yet fully understood; however, dysregulated activation of the innate immune response is considered a key factor in the pathogenesis of this condition (\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e, \u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eIn the present study, we analyzed 56 children with a history of recurrent fevers. PFAPA syndrome was diagnosed in 47 of them, and these patients were included in the subsequent analyses.\u003c/p\u003e \u003cp\u003ePFAPA typically occurs in children under 5 years of age (\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan additionalcitationids=\"CR16\" citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e). In our cohort, febrile episodes began before the age of 5 years in 91.5% of cases (43 children). Moreover, the median age at onset of the first febrile episode was 2 years, which is consistent with findings by Lazea, Rydenman, Yildiz, and Chen et al., who reported a median age at onset ranging from 1.5 to 3.5 years (\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e, \u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e). We observed a slight predominance of boys (59.6%), in line with current epidemiological data indicating a higher incidence in males. Similar results were reported by Lazea et al., who found that boys accounted for 56.4% of cases (\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eIn our study, the median duration of febrile episodes was 5 days, and the median interval between episodes was approximately 3 weeks. These findings are consistent with the results reported by Rydenman, Moberg, and Luu et al., in which febrile episodes lasted 3\u0026ndash;5 days and occurred every 3\u0026ndash;5 weeks (\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e, \u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e). The collected data confirm that PFAPA is a cyclical disease characterized by a recurrent pattern of febrile episodes. In most patients, both the duration of episodes and the intervals between them remain relatively stable and regular.\u003c/p\u003e \u003cp\u003eApart from high-grade fever, which was present in all patients, the most common clinical manifestations in our cohort were cervical lymphadenopathy (91.5%), pharyngitis or tonsillitis (74.5%), tonsillar exudates (85.1%), and oral aphthae (51.1%). The literature indicates that pharyngitis and tonsillitis occur in approximately 90% of patients and are frequently accompanied by mucosal erythema and whitish exudates on the tonsils. Cervical lymph node enlargement is observed in 53\u0026ndash;94% of cases, while small, painful oral ulcers affect more than half of patients (\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e, \u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e, \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e, \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e). Ezeh, Broide, and colleagues have reported cases in which PFAPA was associated with abdominal or joint pain (\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e, \u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eIt should be emphasized that symptoms during febrile episodes usually do not occur simultaneously and vary in severity between patients. In the present study, no significant associations were found between the number of clinical manifestations and the age at onset of the first febrile episodes, the length of afebrile intervals, or the time to diagnosis. Moreover, there were no statistically significant differences in the duration of febrile episodes among patients presenting with one, two, or three clinical features.\u003c/p\u003e \u003cp\u003eLaboratory results were analyzed in 9 patients. All showed elevated inflammatory markers (CRP, ESR, PCT). The mean values were: CRP 6.9 mg/dL, ESR 35 mm/h, and PCT 0.68 ng/mL. Similar findings were reported by Lazea and Chen et al., who described mean CRP values of 6.8 mg/L and 7.9 mg/dL and ESR values of 40 mm/h and 28.5 mm/h, respectively. In the study by Yazgan et al., the mean PCT concentration was 0.29\u0026thinsp;\u0026plusmn;\u0026thinsp;0.14 ng/mL (\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e, \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e, \u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e). High CRP and ESR levels together with moderately elevated PCT values are characteristic of febrile flares in PFAPA syndrome. These parameters reflect activation of the immune system and provide important diagnostic support in recognizing this condition.\u003c/p\u003e \u003cp\u003ePharmacologic treatment of PFAPA syndrome consists of oral glucocorticoids administered at a dose of 0.5\u0026ndash;2 mg/kg on the first day of fever onset. These agents effectively alleviate symptoms but do not prevent disease recurrence. In approximately two-thirds of patients, a single dose is sufficient to achieve an antipyretic effect (\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e). In the absence of clinical response, a repeat dose after 24 hours is recommended. Only about 5% of patients show complete lack of response to this therapy (\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e). The characteristic rapid clinical response to glucocorticoids is also frequently used as an additional diagnostic criterion for PFAPA (\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eThe literature also highlights the role of maintenance and prophylactic therapies, such as colchicine at a dose of 0.5\u0026ndash;1.25 mg/day and cimetidine at 10\u0026ndash;20 mg/kg/day divided into two doses (\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e, \u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eIn our study, prednisone at a dose of 1 mg/kg body weight proved effective, having been administered to 87.2% of patients and resulting in clinical improvement in 97.6% of cases. Only one child receiving oral glucocorticoids failed to respond to treatment. A similarly high efficacy of glucocorticoid therapy, ranging from 94% to 100%, has been reported by Lazea, Kanik, Yildiz, and Ezeh et al. (\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e, \u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e, \u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e). Prednisone treatment was associated with changes in the length of intervals between febrile episodes. In 58.5% of patients, an extension of inter-episode periods was observed, whereas in 12.2% these intervals became shorter. Lazea et al. reported that oral glucocorticoid administration prolonged the intervals between attacks in 13% of patients and shortened them in 35% (\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e). A shortening of inter-episode intervals in 46% of patients was also described by Broide et al. (\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eThese findings confirm that glucocorticoids are highly effective in rapidly terminating febrile episodes and alleviating PFAPA symptoms. Nevertheless, oral administration may paradoxically be associated with shorter afebrile intervals. This phenomenon has a complex background, potentially involving suboptimal treatment efficacy, the development of pharmacologic tolerance, or inappropriate adjustment of the therapeutic regimen. To optimize disease control and improve quality of life, close monitoring and careful, individualized dose titration are therefore essential.\u003c/p\u003e \u003cp\u003eAs noted above, pharmacologic treatment of PFAPA does not prevent disease recurrence. Tonsillectomy represents a key therapeutic option in affected children, with reported effectiveness ranging from 70% to 97% (\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e, \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e, \u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e, \u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e, \u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e, \u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e, \u003cspan additionalcitationids=\"CR32\" citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e). In our study, tonsillectomy was performed in 25.5% of patients, resulting in complete remission in 83.3% of them.\u003c/p\u003e \u003cp\u003eWhen analyzing factors influencing surgical outcomes, Hara et al. observed complete remission after tonsillectomy in 73.6% of children. Moreover, onset of PFAPA symptoms at \u0026ge;\u0026thinsp;36 months of age and the presence of headache were associated with a higher likelihood of complete resolution following the procedure (\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eTo minimize the risk of complications and to accelerate recovery, clinical practice is increasingly shifting from classic tonsillectomy to tonsillotomy (\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e). This procedure is associated with a significantly lower risk of postoperative hemorrhage, reduced postoperative pain, and a faster return to daily activities. For these reasons, tonsillotomy is particularly recommended in younger children and in patients at increased risk of complications (\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eSimilar to tonsillectomy, tonsillotomy markedly reduces the number of febrile days during the course of the disease. Studies have shown that the difference in the cure rate between children undergoing tonsillotomy and those receiving conservative treatment alone is 40 percentage points, which represents a clinically meaningful therapeutic effect (\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eAn important consideration is the long-term effect of tonsillectomy in patients with recurrent fevers. Although long-term follow-up was not conducted in the present study, the literature provides evidence that the benefits of this procedure may persist for many years. In the study by Lantto et al., with a follow-up period of 9.8 years, as many as 95% of children maintained complete remission after surgery (\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e). Analysis of the relationship between disease relapse and prior tonsillectomy revealed that late recurrences were associated with regrowth of the palatine tonsils. In such cases, repeat tonsillectomy was performed, leading to restoration of remission in most patients (\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e). These observations are particularly relevant in the context of tonsillotomy, in which residual tonsillar lymphoid tissue may contribute to secondary hypertrophy (\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e). The correlation between tonsillar regrowth and disease relapse suggests that PFAPA‑associated inflammation may result from aberrant activation of immune cells within the tonsils, as well as from inflammatory signals originating in other tissues or from microbial stimuli (\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e, \u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e37\u003c/span\u003e). In our study, among the 34 children who did not undergo tonsillectomy, 11 (32.4%) reported complete resolution of symptoms. Broide et al. indicated that in most children, symptoms spontaneously abate before 14 years of age, confirming the self‑limiting nature of the disease (\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e). Nevertheless, this process is preceded by numerous episodes of recurrent fever, which often leads clinicians to consider tonsillectomy or the initiation of pharmacologic treatment (\u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e38\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eStudies suggest that later age at onset, absence of myalgia, and a good response to glucocorticoids may represent favorable prognostic factors for remission after tonsillectomy (\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e, \u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e). Further prospective studies are needed to confirm these observations and to identify additional predictive factors.\u003c/p\u003e \u003cp\u003eA major clinical concern is the issue of misdiagnosis and inappropriate antibiotic use in patients with unrecognized PFAPA syndrome. In their study, Rydenman et al. demonstrated a 61.8% reduction in antibiotic prescriptions following the establishment of a PFAPA diagnosis (\u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e39\u003c/span\u003e). This finding underscores the pivotal role of accurate differential diagnosis in limiting unnecessary antibiotic therapy, which has important public health implications in the context of rising antimicrobial resistance. These results highlight the need to increase clinicians\u0026rsquo; awareness of the clinical features of PFAPA and to develop more effective diagnostic algorithms for this condition.\u003c/p\u003e \u003cp\u003eAlthough the present study provides valuable descriptive information on PFAPA syndrome, it is subject to several important limitations. First, the retrospective and descriptive design, based on questionnaire data, limits the ability to draw causal inferences. Another significant concern is the recruitment method via internet portals, which may introduce selection bias. The resulting sample may not be representative of the general population of children with PFAPA. The retrospective collection of data through questionnaires also carries a risk of recall bias, potentially affecting the accuracy of information on age at symptom onset, episode frequency, and treatment effectiveness. It should also be noted that objective laboratory data, which are crucial for diagnosis and monitoring, were available for only a very small subgroup of patients (n\u0026thinsp;=\u0026thinsp;9), precluding robust conclusions in this area.\u003c/p\u003e \u003cp\u003eIn light of these limitations, further research on PFAPA syndrome is essential. Future prospective studies involving larger patient cohorts are needed to confirm the present observations, reduce selection and recall bias, and provide data with greater statistical power. Such an approach will enable more reliable conclusions, contributing to a better understanding of the pathophysiology of PFAPA, improved diagnostic processes, and optimization of therapeutic strategies in this patient group.\u003c/p\u003e"},{"header":"Conclusions","content":"\u003cp\u003eThis study, based on an analysis of cases in a Polish pediatric population, confirms the established epidemiologic and clinical profile of PFAPA syndrome, characterized by typical features of periodic fever and a favorable response to glucocorticoid therapy and tonsillectomy. These observations underscore the importance of early and accurate diagnosis to reduce unnecessary antibiotic use. Although the findings reinforce existing evidence, the retrospective design and limited sample size warrant caution in their interpretation.\u003c/p\u003e"},{"header":"Abbreviations","content":"\u003cp\u003ePFAPA - periodic fever, aphthous stomatitis, pharyngitis, cervical adenopathy\u003c/p\u003e\n\u003cp\u003eFMF - Familial Mediterranean Fever\u003c/p\u003e\n\u003cp\u003eMKD - Mevalonate Kinase Deficiency\u003c/p\u003e\n\u003cp\u003eTRAPS - Tumor Necrosis Factor Receptor–Associated Periodic Syndrome\u003c/p\u003e\n\u003cp\u003eCAPS - Cryopyrin‑Associated Periodic Syndromes\u003c/p\u003e\n\u003cp\u003eCRP - C‑reactive protein\u003c/p\u003e\n\u003cp\u003eESR - Erythrocyte Sedimentation Rate\u003c/p\u003e\n\u003cp\u003ePCT – Procalcitonin\u003c/p\u003e\n\u003cp\u003eWIM-PIB - Military Institute of Medicine – National Research Institute\u003c/p\u003e\n\u003cp\u003eWBC – White Blood Count\u0026nbsp;\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eEthics approval and consent to participate\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eDue to the retrospective, questionnaire‑based design of the study, the Bioethics Committee of the Military Institute of Medicine – National Research Institute exempted it from further ethical review (registration no. KB/61/25).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent for publication\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eInformed consent was obtained from all legal guardians of all study participants prior to their enrollment in the research. They were thoroughly informed about the study objectives, procedures, potential risks, and benefits, and they were given the opportunity to ask questions before providing their consent.\u0026nbsp;Due to the retrospective, questionnaire‑based design of the study, the Bioethics Committee of the Military Institute of Medicine – National Research Institute exempted it from further ethical review (registration no. KB/61/25).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAvailability of data and materials\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe datasets used during the current review are available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare no conflicts of interest.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis research received no external funding.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors' contributions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eOriginal concept of study: A.T., A.B.; Collection, recording and/or compilation of data N.G., A.K., A.K. .; analysis and interpretation of data: N.G., A.Z., A.B., A.T.; Writing of manuscript: N.G., A.T., A.K., A.K., A.T., A.B.; Critical review of manuscript: A.B., A.T., B.K., A.R.; Final approval of manuscript: B.K. A.R.; All authors have read and agreed to the published version of the manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eClinical trial number\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable.\u0026nbsp;\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eRydenman K, Fjeld H, H\u0026auml;tting J, Berg S, Fasth A, Wekell P. Epidemiology and clinical features of PFAPA: a retrospective cohort study of 336 patients in western Sweden. Pediatr Rheumatol Online J. 2022;20(1):82.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHofer M, Pillet P, Cochard MM, Berg S, Krol P, Kone-Paut I, et al. International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology (Oxford). 2014;53(6):1125\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWang A, Manthiram K, Dedeoglu F, Licameli GR. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a review. World J Otorhinolaryngol Head Neck Surg. 2021;7(3):166\u0026ndash;73.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKanık A, Elia\u0026ccedil;ık K, Kanık ET, Demir\u0026ccedil;elik Y, Demir BK. A comparative study for the clinical features in children with PFAPA syndrome who were diagnosed before and after the age of five. Int J Pediatr Otorhinolaryngol. 2022;158:111153.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWurster VM, Carlucci JG, Feder HM, Edwards KM. Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome. J Pediatr. 2011;159(6):958\u0026ndash;64.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKraszewska-Głomba B, Szymańska-Toczek Z, Szenborn L. Procalcitonin and C-reactive protein-based decision tree model for distinguishing PFAPA flares from acute infections. Bosn J Basic Med Sci. 2016;16(2):157\u0026ndash;61.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWolska-Kuśnierz B, Mikołuć B, Motkowski R, Bernatowska E. PFAPA syndrome - common challenge for pediatrician, immunologist and otolaryngologist. Stand Med Pediatr. 2013;10:794\u0026ndash;800.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eFederici S, Gattorno M. A practical approach to the diagnosis of autoinflammatory diseases in childhood. Best Pract Res Clin Rheumatol. 2014;28(2):263\u0026ndash;76.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAhmadinejad Z, Mansori S, Ziaee V, Alijani N, Aghighi Y, Parvaneh N, et al. Periodic fever: a review on clinical, management and guideline for Iranian patients \u0026ndash; Part I. Iran J Pediatr. 2014;24(1):1\u0026ndash;13.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eThomas KT, Feder HM, Lawton AR, Edwards KM. Periodic fever syndrome in children. J Pediatr. 1999;135(1):15\u0026ndash;21.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCavalcante LFF, Costa G, Battistuta SM, Makabe PF, Bueno ISF, Yuamoto B, et al. Surgical management for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome: a systematic review and meta-analysis. J Pediatr (Rio J). 2025;101(4):494\u0026ndash;500.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAnselmi F, Dusser P, Kone-Paut I. Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children - from pathogenesis to treatment strategies: a comprehensive review. Pediatr Drugs. 2025;27(5):575\u0026ndash;92.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAkelma AZ, Cizmeci MN, Kanburoglu MK, Mete E, Bozkaya D, Tufan N, et al. Is PFAPA syndrome really a sporadic disorder or is it genetic? Med Hypotheses. 2013;81(2):279\u0026ndash;81.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eManthiram K. What is PFAPA syndrome? Genetic clues about the pathogenesis. Curr Opin Rheumatol. 2023;35(6):423\u0026ndash;8.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHaracz J, Tadla M, Fleszar G, Postępski J. PFAPA syndrome in a 2-year-old girl: a case report and literature review. Pediatr Med Rodz. 2018;14(1):88\u0026ndash;95.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eVanoni F, Theodoropoulou K, Hofer M. PFAPA syndrome: a review on treatment and outcome. Pediatr Rheumatol Online J. 2016;14:38.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMichailou M, Perdikogianni C. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: an update. Child (Basel). 2025;12(4):446.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLazea C, Damian L, Vulturar R, Lazar C. PFAPA syndrome: clinical, laboratory and therapeutic features in a single-centre cohort. Int J Gen Med. 2022;15:6871\u0026ndash;80.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRydenman K, Fjeld H, H\u0026auml;tting J, Berg S, Fasth A, Wekell P. Epidemiology and clinical features of PFAPA: a retrospective cohort study of 336 patients in western Sweden. Pediatr Rheumatol Online J. 2022;20(1):82.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eYildiz M, Haslak F, Adrovic A, Gucuyener N, Ulkersoy I, Koker O, et al. Independent risk factors for resolution of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome within 4 years after the disease onset. Clin Rheumatol. 2021;40(5):1959\u0026ndash;65.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eChen X, Li Y, Yang M, Shu Z, Mao H. Periodic fever syndromes in Chinese children and adolescents: a single-centre cohort study. Research Square [Preprint]. 2024. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.researchsquare.com/article/rs-4411739/v1\u003c/span\u003e\u003cspan address=\"https://www.researchsquare.com/article/rs-4411739/v1\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMoberg T, Rydenman K, Berg S, Fasth A, Wekell P. Long-term symptoms in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome after tonsillectomy. J Pediatr. 2025;278:114424.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLuu I, Sharma A, Guaderrama M, Peru M, Nation J, Page N, et al. Immune dysregulation in the tonsillar microenvironment of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome. J Clin Immunol. 2020;40(1):179\u0026ndash;90.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eYıldız M, Haslak F, Adrovic A, \u0026Uuml;lkersoy İ, G\u0026uuml;c\u0026uuml;yener N, Şahin S, et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: a single-center experience. Turk Arch Pediatr. 2022;57(1):46\u0026ndash;52.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eZuchniak P, Godek G, Klajda K, Sidorczuk P, Kr\u0026oacute;l O, Wysokińska O. The PFAPA syndrome: review on diagnosis and management. J Educ Health Sport. 2022;12(12):67\u0026ndash;73.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eEzeh UC, Kahn PJ, April MM. Management of periodic fever, aphthous stomatitis, pharyngitis, and adenitis with intracapsular tonsillectomy. Laryngoscope. 2024;134(4):1967\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBroide M, Levinsky Y, Tal R, Harel L, Shoham S, Abu Ahmad S, et al. Extreme periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA): a discrete group of patients. Pediatr Rheumatol Online J. 2023;21:59.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eYazgan H, Keleş E, Yazgan Z, Gebeş\u0026ccedil;e A, Demird\u0026ouml;ven M. C-reactive protein and procalcitonin during febrile attacks in PFAPA syndrome. Int J Pediatr Otorhinolaryngol. 2012;76(8):1145\u0026ndash;7.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHausmann J, Dedeoglu F, Broderick L. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome and syndrome of unexplained recurrent fevers in children and adults. J Allergy Clin Immunol Pract. 2023;11(6):1676\u0026ndash;87.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAmarilyo G, Rothman D, Manthiram K, Edwards KM, Li SC, Marshall GS, et al. Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) PFAPA work group. Pediatr Rheumatol Online J. 2020;18(1):31.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBanh Chong T, Sagot O, Alexis M, Brehin C, Brochard K, Gallois Y. Efficacy of partial tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: a STROBE retrospective observational study. Eur Ann Otorhinolaryngol Head Neck Dis. 2025;142(3):115\u0026ndash;20.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRydenman K, Sparud-Lundin C, Karlsson-Bengtsson A, Berg S, Fasth A, Wekell P. Tonsillectomy reduces the family impact of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome and improves health-related quality of life in affected children. Orphanet J Rare Dis. 2023;18:146.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eManthiram K, Ortega-Villa AM, Lapidus S, Bowes M, Romeo T, Garguilo K, et al. Features associated with response to tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome in children. J Pediatr. 2025;282:114559.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHara M, Morimoto N, Watabe T, Morisaki N, Matsumoto K. Can the effectiveness of tonsillectomy for PFAPA syndrome be predicted based on clinical factors. Int J Rheum Dis. 2023;26(3):480\u0026ndash;6.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLantto U, Tapiainen T, Pokka T, Koivunen P, Helminen M, Piitulainen J, et al. Tonsillotomy for periodic fever syndrome: a randomized and controlled trial. Laryngoscope. 2024;134(2):968\u0026ndash;72.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eBurton MJ, Pollard AJ, Ramsden JD, Chong LY, Venekamp RP. Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome (PFAPA). Cochrane Database Syst Rev. 2019;12:CD008669.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKaliszczuk M, Drążek K, Stańczyk M, Tkaczyk M. Periodic fever in everyday paediatric practice - case report of 6-year-old girl and a literature review. Pediatr Med Rodz. 2020;16(1):100\u0026ndash;3.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMr\u0026oacute;wka-Kata K, Kata D, Miśkiewicz-Orczyk K, Namysłowski P. PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, cervical adenopathy). Ann Acad Med Siles. 2012;66(1):57\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRydenman K, Berg S, Karlsson-Bengtsson A, Fasth A, Wekell P. Antibiotic prescriptions to children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis. Acta Paediatr. 2024;113(8):1927\u0026ndash;33.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"PFAPA, recurrent fever, stomatitis, pharyngitis, cervical adenitis","lastPublishedDoi":"10.21203/rs.3.rs-8368110/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-8368110/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003eObjective\u003c/h2\u003e \u003cp\u003ePFAPA syndrome is the most common autoinflammatory disease of childhood, with an as yet unknown etiology. It is characterized by recurrent, periodic episodes of fever accompanied by specific clinical features. Its pathogenesis and clinical course remain the subject of ongoing research. The aim of this study was to provide a detailed characterization of PFAPA syndrome in a large Polish pediatric cohort.\u003c/p\u003e\u003ch2\u003eMethods\u003c/h2\u003e \u003cp\u003eWe conducted a retrospective cross-sectional study based on data from 47 children with a confirmed diagnosis of PFAPA syndrome. Data were collected using structured questionnaires. Detailed analyses included clinical manifestations, therapeutic approaches, and laboratory findings.\u003c/p\u003e\u003ch2\u003eResults\u003c/h2\u003e \u003cp\u003eThe median age of the study population was 5 years, with a predominance of males (59.6%). In 91.5% of patients, the first episode of fever occurred before the age of 5 years. Febrile episodes lasted a mean of 5 days, with a median inter-episode interval of 3 weeks. The key clinical manifestations included cervical lymphadenopathy (91.5%), tonsillar exudates (85.1%), pharyngitis (74.5%), and oral aphthae (51.1%). During afebrile intervals, 87.2% of patients were free of symptoms. Laboratory evaluation showed elevated inflammatory markers, with a median C-reactive protein level of 6.9 mg/dL, a median erythrocyte sedimentation rate of 35.0 mm/h, and a mean neutrophil count of 11.8 \u0026times; 10^3/\u0026micro;L. Prednisone treatment was effective in 97.6% of cases.\u003c/p\u003e","manuscriptTitle":"Epidemiology and Clinical Course of PFAPA Syndrome in the Pediatric Population","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-12-26 09:47:41","doi":"10.21203/rs.3.rs-8368110/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"74a38ef8-7e1c-441f-a344-7a1e09eb50d3","owner":[],"postedDate":"December 26th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2026-01-10T09:09:19+00:00","versionOfRecord":[],"versionCreatedAt":"2025-12-26 09:47:41","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-8368110","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-8368110","identity":"rs-8368110","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00